New items on the 2020 federal regulatory agenda include DEA’s plan to clarify which locations registrants should consider to be their principal place of business or professional practice for purposes of compliance with the Controlled Substances Act. Other new items on the agenda, updated semi-yearly online, include updated rules for bulk marijuana manufacturing and more rule change... Read More